What is the share price of Tatva Chintan Pharma Chem Ltd (TATVA) today?
The share price of TATVA as on 1st July 2025 is ₹952.90. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Tatva Chintan Pharma Chem Ltd (TATVA) share?
The past returns of Tatva Chintan Pharma Chem Ltd (TATVA) share are- Past 1 week: 3.88%
- Past 1 month: 5.80%
- Past 3 months: 34.73%
- Past 6 months: 10.89%
- Past 1 year: -16.06%
- Past 3 years: -58.61%
- Past 5 years: -58.79%
What are the peers or stocks similar to Tatva Chintan Pharma Chem Ltd (TATVA)?
The peers or stocks similar to Tatva Chintan Pharma Chem Ltd (TATVA) include:What is the dividend yield % of Tatva Chintan Pharma Chem Ltd (TATVA) share?
The current dividend yield of Tatva Chintan Pharma Chem Ltd (TATVA) is 0.10.What is the market cap of Tatva Chintan Pharma Chem Ltd (TATVA) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Tatva Chintan Pharma Chem Ltd (TATVA) is ₹2229.03 Cr as of 1st July 2025.What is the 52 week high and low of Tatva Chintan Pharma Chem Ltd (TATVA) share?
The 52-week high of Tatva Chintan Pharma Chem Ltd (TATVA) is ₹1199.95 and the 52-week low is ₹621.What is the PE and PB ratio of Tatva Chintan Pharma Chem Ltd (TATVA) stock?
The P/E (price-to-earnings) ratio of Tatva Chintan Pharma Chem Ltd (TATVA) is 390.37. The P/B (price-to-book) ratio is 3.02.Which sector does Tatva Chintan Pharma Chem Ltd (TATVA) belong to?
Tatva Chintan Pharma Chem Ltd (TATVA) belongs to the Materials sector & Specialty Chemicals sub-sector.How to buy Tatva Chintan Pharma Chem Ltd (TATVA) shares?
You can directly buy Tatva Chintan Pharma Chem Ltd (TATVA) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Tatva Chintan Pharma Chem Ltd
TATVA Share Price
952.900.00% (+0.00)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
TATVA Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is overpriced but is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
TATVA Performance & Key Metrics
TATVA Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 389.69 | 3.02 | 0.10% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 28.03 | 3.53 | 1.57% |
33%
Analysts have suggested that investors can buy this stock
from 3 analysts
Price Upside
Earnings Growth
Rev. Growth
TATVA Company Profile
Tatva Chintan Pharma Chem is engaged in the manufacturing business of chemical products.
FLUOROCHEM
PE Ratio
71.68
71.68
1Y Return
8.51%
8.51%
Buy Reco %
55.56
55.56
NAVINFLUOR
PE Ratio
83.99
83.99
1Y Return
34.98%
34.98%
Buy Reco %
61.54
61.54
VINATIORGA
PE Ratio
50.02
50.02
1Y Return
2.92%
2.92%
Buy Reco %
83.33
83.33
AARTIIND
PE Ratio
53.06
53.06
1Y Return
31.27%
31.27%
Buy Reco %
70.59
70.59
SPLPETRO
PE Ratio
40.55
40.55
1Y Return
8.64%
8.64%
Buy Reco %
100.00
100.00
TATVA Sentiment Analysis
TATVA Sentiment Analysis
New
Crisp summary & key insights to decode earnings calls instantly
TATVA Stock Summary · May 2025
In the fourth quarter of FY2025, the company reported a revenue growth of 10% year-on-year, despite a significant 43% decline in EBITDA, reflecting operational challenges amid a tough macroeconomic environment. While segments like Phase Transfer Catalysts and Structure-Directing Agents showed promising demand, the Electrolyte Salts faced setbacks, highlighting a mixed market sentiment. Strategic adjustments are underway, including a focus on high-purity materials and the agrochemical sector, where growth projections range from 40% to 70%. Despite fluctuations in raw material prices and operational inefficiencies, management remains optimistic about future profitability, driven by new product commercialization and enhanced customer engagement. The anticipated recovery in demand, particularly in the hybrid vehicle battery sector, further supports a positive outlook for the upcoming fiscal year.
TATVA Stock Growth Drivers
TATVA Stock Growth Drivers
8Strong Financial Performance
The company reported a revenue from operations of ₹1,079 million, reflecting a 10% year-on-year growth
Commitment to Innovation and Sustainability
The company has made notable progress in innovation and sustainability, particularly in the production of
TATVA Stock Challenges
TATVA Stock Challenges
7Declining Financial Performance
The company reported a significant decline in EBITDA and profit after tax (PAT) for Q4
Operational Inefficiencies
The company faced significant operational challenges during the commercialization of four agro intermediates, leading to
TATVA Forecast
TATVA Forecasts
Price
Revenue
Earnings
TATVA Share Price Forecast
TATVA Share Price Forecast
2025
Current
₹952.90
Baseline
Forecast for Jul 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹952.90
Baseline
Forecast for Jul 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
TATVA Company Revenue Forecast
TATVA Company Revenue Forecast
2025
Current
₹385.03
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
2025
Current
₹385.03
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹ cr.
TATVA Stock EPS (Earnings Per Share) Forecast
TATVA Stock EPS (Earnings Per Share) Forecast
2025
Current
₹2.44
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
2025
Current
₹2.44
Baseline
Forecast for Mar 2026
High
₹—
Median
₹—
Low
₹—
All values in ₹
TATVA
TATVA
Income
Balance Sheet
Cash Flow
Annual Normal View
TATVA Income Statement
TATVA Income Statement
Annual Normal View
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 137.29 | 207.55 | 264.62 | 305.56 | 442.54 | 429.35 | 401.01 | 385.03 | 385.04 | |||||||||
Raw Materials | 74.16 | 118.57 | 148.61 | 156.06 | 258.17 | 220.39 | 182.36 | 348.50 | 348.50 | |||||||||
| Power & Fuel Cost | 4.65 | 6.25 | 8.96 | 9.92 | 22.62 | 23.61 | 34.78 | |||||||||||
| Employee Cost | 12.27 | 16.31 | 20.53 | 23.80 | 30.81 | 41.21 | 54.76 | |||||||||||
| Selling & Administrative Expenses | 16.15 | 25.04 | 27.15 | 30.70 | 51.99 | 44.94 | 39.13 | |||||||||||
| Operating & Other expenses | 5.45 | 6.02 | 2.72 | 13.20 | -38.46 | 36.27 | 14.08 | |||||||||||
EBITDA | 24.61 | 35.36 | 56.65 | 71.88 | 117.41 | 62.93 | 75.90 | 36.53 | 36.54 | |||||||||
| Depreciation/Amortization | 2.95 | 4.02 | 4.79 | 6.73 | 8.18 | 9.56 | 25.61 | 27.66 | 27.66 | |||||||||
| PBIT | 21.66 | 31.34 | 51.86 | 65.15 | 109.23 | 53.37 | 50.29 | 8.87 | 8.88 | |||||||||
| Interest & Other Items | 2.63 | 3.95 | 4.27 | 4.45 | 5.11 | 8.60 | 6.73 | 1.29 | 1.29 | |||||||||
| PBT | 19.03 | 27.39 | 47.59 | 60.70 | 104.12 | 44.77 | 43.56 | 7.58 | 7.59 | |||||||||
| Taxes & Other Items | 6.75 | 6.85 | 9.81 | 8.43 | 8.25 | -0.70 | 13.22 | 1.87 | 1.87 | |||||||||
| Net Income | 12.28 | 20.54 | 37.78 | 52.27 | 95.87 | 45.47 | 30.34 | 5.71 | 5.72 | |||||||||
| EPS | 6.11 | 10.23 | 18.81 | 26.02 | 45.38 | 20.51 | 13.32 | 2.44 | 2.45 | |||||||||
| DPS | 0.00 | 0.00 | 0.00 | 5.00 | 2.00 | 2.00 | 2.00 | 1.00 | 2.00 | |||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.19 | 0.04 | 0.10 | 0.15 | 0.41 | 0.82 |
TATVA Company Updates
FY 2025FY 2025
Investor Presentation
May 5PDF
Jan 28PDF
Oct 25PDF
TATVA Stock Peers
TATVA Past Performance & Peer Comparison
TATVA Past Performance & Peer Comparison
Comparing 3 stocks from
MaterialsSpecialty Chemicals
Compare valuation-basic on Screener
MaterialsSpecialty Chemicals
Valuation
Technical
Forecast
Compare valuation-basic on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Tatva Chintan Pharma Chem Ltd | 390.37 | 3.02 | 0.10% |
| Gujarat Fluorochemicals Ltd | 71.68 | 6.59 | 0.08% |
| Navin Fluorine International Ltd | 83.99 | 10.17 | 0.25% |
| Vinati Organics Ltd | 50.02 | 8.24 | 0.38% |
TATVA Stock Price Comparison
Compare TATVA with any stock or ETFCompare TATVA with any stock or ETF
TATVA
TATVA Holdings
TATVA Shareholdings
TATVA Promoter Holdings Trend
TATVA Promoter Holdings Trend
Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better
Pledged promoter holdings is insignificant
TATVA Institutional Holdings Trend
TATVA Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
TATVA Shareholding Pattern
TATVA Shareholding Pattern
TATVA Shareholding History
TATVA Shareholding History
Foreign Institutions
Mutual Funds Invested in TATVA
Mutual Funds Invested in TATVA
No mutual funds holding trends are available
Top 4 Mutual Funds holding Tatva Chintan Pharma Chem Ltd
| Funds (Top 4) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
The rupee value of the stock held by the fund divided by the stock’s market cap 3.1131% | Percentage of the fund’s portfolio invested in the stock 0.46% | Change in the portfolio weight of the stock over the last 3 months 0.06% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 57/67 (+1) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.9368% | Percentage of the fund’s portfolio invested in the stock 0.25% | Change in the portfolio weight of the stock over the last 3 months 0.00% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 79/132 (+2) | |
The rupee value of the stock held by the fund divided by the stock’s market cap 0.6480% | Percentage of the fund’s portfolio invested in the stock 0.90% | Change in the portfolio weight of the stock over the last 3 months 0.15% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 39/60 (-1) |
Compare 3-month MF holding change on Screener
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing TATVA stock
smallcases containing TATVA stock
Looks like this stock is not in any smallcase yet.
TATVA Events
TATVA Events
TATVA Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.10%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.05 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
TATVA Dividend Trend
Dividend Yield
Dividend return is one of the most important things to be considered while investing for long term. It is the additional return on top of what investors earn through price appreciation
Current dividend yield is 0.10%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹1.05 every year
TATVA Upcoming Dividends
TATVA Upcoming Dividends
No upcoming dividends are available
TATVA Past Dividends
TATVA Past Dividends
Cash Dividend
Ex DateEx DateSep 6, 2024
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 6, 2024
Cash Dividend
Ex DateEx DateSep 8, 2023
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 8, 2023
Cash Dividend
Ex DateEx DateSep 8, 2022
Final
Final | Div/Share: ₹2.00
Dividend/Share
₹2.00
Ex DateEx Date
Sep 8, 2022
TATVA Stock News & Opinions
TATVA Stock News & Opinions
Articles & Videos
Corporate
Tatva Chintan Pharma Chem wins export order of USD 35,55,000
Tatva Chintan Pharma Chem has received an export order worth of USD 35,55,000 (approx. Rs 29.95 crore) excluding tax for supply of Specialty Chemicals under Pharma & Agro Intermediates & Speciality Chemicals (PASC) category, to be delivered in November / December 2025 (Q3 FY26).Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Tatva Chintan Pharma Chem consolidated net profit declines 89.28% in the March 2025 quarter
Net profit of Tatva Chintan Pharma Chem declined 89.28% to Rs 1.03 crore in the quarter ended March 2025 as against Rs 9.61 crore during the previous quarter ended March 2024. Sales rose 9.76% to Rs 107.86 crore in the quarter ended March 2025 as against Rs 98.27 crore during the previous quarter ended March 2024. For the full year,net profit declined 81.19% to Rs 5.71 crore in the year ended March 2025 as against Rs 30.35 crore during the previous year ended March 2024. Sales declined 2.74% to Rs 382.71 crore in the year ended March 2025 as against Rs 393.50 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales107.8698.27 10 382.71393.50 -3 OPM %8.3015.88 -8.9417.33 - PBDT9.2919.92 -53 35.2469.17 -49 PBT2.0313.69 -85 7.5843.57 -83 NP1.039.61 -89 5.7130.35 -81 Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Board of Tatva Chintan Pharma Chem recommends Final Dividend
Tatva Chintan Pharma Chem announced that the Board of Directors of the Company at its meeting held on 02 May 2025, has recommended a Final Dividend of Rs.1 per share (i.e.10%), subject to the approval of the shareholders.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Tatva Chintan Pharma Chem to declare Quarterly Result
Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 2 May 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Tatva Chintan Pharma Chem consolidated net profit declines 95.95% in the December 2024 quarter
Net profit of Tatva Chintan Pharma Chem declined 95.95% to Rs 0.14 crore in the quarter ended December 2024 as against Rs 3.46 crore during the previous quarter ended December 2023. Sales rose 2.01% to Rs 85.90 crore in the quarter ended December 2024 as against Rs 84.21 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales85.9084.21 2 OPM %8.2213.05 - PBDT6.6911.83 -43 PBT-0.245.24 PL NP0.143.46 -96 Powered by Capital Market - Live
5 months agoCapital Market - Live
Corporate
Tatva Chintan Pharma Chem declare Quarterly Result
Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 28 January 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Tatva Chintan Pharma Chem reports consolidated net loss of Rs 0.66 crore in the September 2024 quarter
Net loss of Tatva Chintan Pharma Chem reported to Rs 0.66 crore in the quarter ended September 2024 as against net profit of Rs 7.78 crore during the previous quarter ended September 2023. Sales declined 13.63% to Rs 83.49 crore in the quarter ended September 2024 as against Rs 96.67 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales83.4996.67 -14 OPM %6.6820.94 - PBDT5.7917.99 -68 PBT-1.0211.21 PL NP-0.667.78 PL Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Tatva Chintan Pharma Chem to discuss results
Tatva Chintan Pharma Chem will hold a meeting of the Board of Directors of the Company on 25 October 2024.Powered by Capital Market - Live
8 months agoCapital Market - Live
Corporate
Tatva Chintan Pharma Chem AGM scheduled
Tatva Chintan Pharma Chem announced that the Annual General Meeting (AGM) of the company will be held on 20 September 2024.Powered by Capital Market - Live
10 months agoCapital Market - Live
Purple Finance Ltd leads losers in ‘B’ group
11 months agoBusiness Standard
Over the last 5 years, revenue has grown at a yearly rate of 7.79%, vs industry avg of 11.03%
Over the last 5 years, market share decreased from 0.5% to 0.41%
Over the last 5 years, net income has grown at a yearly rate of -31.47%, vs industry avg of 7.75%